Four patients with GBM were involved in this study, with NTRK1-AFAP1, NTRK1-TPM3, NTRK2-BCR and NTRK4-EML4 fusions, and all patients had a history of neurosurgery, radiotherapy, and adjuvant chemotherapy. The gene discussed is NTRK1; the disease is glioblastoma.